Page tree
Skip to end of metadata
Go to start of metadata

Project meeting schedule

The Real-time Pharmacy Benefit Check project meets the second and fourth Friday between 3-4 pm ET. If you are interested in participating in project activities, please contact

 us.

Ballot Reconciliation calls for the CARIN RTPBC IG will take place during the Friday calls.


Overview

The focus of the CARIN RTPBC project is to develop a co-branded HL7 FHIR® and NCPDP implementation guide for a consumer-facing realtime pharmacy benefit transaction that brings together a patient's pharmacy benefit information and a discount or cash price for a specific medication.  

The project seeks to centralize existing, disparate efforts to accomplish RTPBC, to vet and develop best-in-class policies to accomplish RTPBC, and to collaboratively implement RTPBC with a broad set of stakeholders, including Congress, CMS, and the White House who have expressed strong support for RTPBC solutions.


CARIN RTPBC Patient Facing Implementation Guide (this is still in process and should not be viewed as final)

CARIN RTPBC Implementation Guide Proposal

PSS for CARIN Consumer-facing Real-time Pharmacy Benefit Check 


February 2020 Ballot

The Consumer-facing Real-time Pharmacy Benefit Check FHIR IG went through HL7 balloting in January and we are currently addressing comments from voters.

Here is the balloted FHIR Implementation Guide.


Comment Reconciliation

Comments will be discussed in joint meetings involving the HL7 Pharmacy and Financial Management Workgroups and the CARIN RTPBC Workgroup.

Currently scheduled meetings are at:

  • Thursday March 5 at 11:00 ET
  • Thursday March 19 at 11:00 ET

(No meeting is scheduled for March 12 as many will be attending HIMSS. Additional discussions will be scheduled as needed)

Resolutions will be voted on during regularly-scheduled Pharmacy and Financial Management WG calls.


We are in the process of bringing the comments into Jira, to be worked and resolved there. In the meantime, below is a working copy of the comments, with discussion notes.




  • No labels